Detalhe da pesquisa
1.
PEGylated mesoporous silica core-shell redox-responsive nanoparticles for delivering paclitaxel to breast cancer cells.
Int J Pharm
; 655: 124024, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38537920